The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly: The Rotterdam Study
Open accessAbstract
BACKGROUND: Elevated homocysteine level increases vascular disease risk. Most data are based on subjects younger than 60 years; data for the elderly are more limited. We examined the relationship of homocysteine level to incident myocardial infarction and stroke among older subjects in a nested case-control study. METHODS: Subjects were participants in the Rotterdam Study, a cohort study among 7983 subjects residing in the Ommoord district of Rotterdam, the Netherlands. Baseline examinations were performed from March 1, 1990, to July 31, 1993. The analysis is restricted to myocardial infarction and stroke that occurred before December 31, 1994. One hundred four patients with a myocardial infarction and 120 with a stroke were identified with complete data. Control subjects consisted of a sample of 533 subjects drawn from the study base, free of myocardial infarction and stroke. Nonfasting total homocysteine levels were measured. RESULTS: Results were adjusted for age and sex. The risk of stroke and myocardial infarction increased directly with total homocysteine. The linear coefficient suggested a risk increase by 6% to 7% for every 1-micromol/L increase in total homocysteine. The risk by quintiles of total homocysteine level was significantly increased only in the group with levels above 18.6 micromol/L (upper quintile): odds ratios were 2.43 (95% confidence interval, 1.11-5.35) for myocardial infarction and 2.53 (95% confidence interval, 1.19-5.35) for stroke. Associations were more pronounced among those with hypertension. CONCLUSIONS: The present study, based on a relatively short follow-up period, provides evidence that among elderly subjects an elevated homocysteine level is associated with an increased risk of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Determinants of disease and disability in the elderly: The Rotterdam elderly study
Hofman, A., Grobbee, D. E., De Jong, P. T. V. M., & Van den Ouweland, F. A. (1991) · European Journal of Epidemiology · doi:10.1007/bf00145007 · Cited by 1,129
Self-citationTotal Plasma Homocysteine and Cardiovascular Risk Profile: The Hordaland Homocysteine Study
Nygård, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., Ueland, P. M., & Kvåle, G. (1995) · JAMA · doi:10.1001/jama.1995.03530190040032 · Cited by 1,042
Araki, A., & Sako, Y. (1987) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80438-3 · Cited by 1,041
(1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90073-5 · Cited by 993
Total homocysteine in plasma or serum: methods and clinical applications
Ueland, P. M., Refsum, H., Stabler, S. P., Malinow, M. R., Andersson, A., & Allen, R. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.9.1764 · Cited by 981
Harker, L. A., Ross, R., Slichter, S. J., & Scott, C. R. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108520 · Cited by 933
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
Ubbink, J. B., Hayward Vermaak, W. J., & Bissbort, S. (1991) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80407-4 · Cited by 678
Serum Total Homocysteine and Coronary Heart Disease
ARNESEN, E., REFSUM, H., BØNAA, K. H., UELAND, P. M., FØRDE, O. H., & NORDREHAUG, J. E. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.704 · Cited by 651
Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkäniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., & Ehnholm, C. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90078-7 · Cited by 527
Verhoef, P., Stampfer, M. J., Buring, J. F., Gaziano, J. M., Allen, R. H., Stabler, S. P., Reynolds, R. D., Kok, F. J., Hennekens, C. H., & Willett, W. C. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008828 · Cited by 480
Ma, J., Stampfer, M. J., Hennekens, C. H., Frosst, P., Selhub, J., Horsford, J., Malinow, M. R., Willett, W. C., & Rozen, R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2410 · Cited by 479
Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E., & Bond, G. (1993) · Circulation · doi:10.1161/01.cir.87.4.1107 · Cited by 451
Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjects
BRATTSTRÖM, L., LINDGREN, A., ISRAELSSON, B., ANDERSSON, A., & HULTBERG, B. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00856.x · Cited by 381
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J. (1994) · Stroke · doi:10.1161/01.str.25.10.1924 · Cited by 379
Naurath, H. J., Joosten, E., Riezler, R., Stabler, S., Allen, R. H., & Lindenbaum, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92113-3 · Cited by 285
Homocyst(e)ine and arterial occlusive diseases
MALINOW, M. R. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00854.x · Cited by 247
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study
Nygard, O. K. (1995) · JAMA · doi:10.1001/jama.274.19.1526 · Cited by 234
Guttormsen, A. B., Schneede, J., Fiskerstrand, T., Ueland, P. M., & Refsum, H. M. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.10.1934 · Cited by 191
Vitamins as Homocysteine-Lowering Agents
Brattström, L. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.suppl_4.1276s · Cited by 175
van Gent, C. M., van der Voort, H. A., Bruyn, A. M. D., & Klein, F. (1977) · Clinica Chimica Acta · doi:10.1016/0009-8981(77)90195-4 · Cited by 131
The effect of blood sample aging and food consumption on plasma total homocysteine levels
Ubbink, J., Vermaak, W. J. H., van der Merwe, A., & Becker, P. (1992) · Clinica Chimica Acta · doi:10.1016/0009-8981(92)90155-j · Cited by 131
Prevalence of Stroke in the General Population
Bots, M. L., Looman, S. J., Koudstaal, P. J., Albert Hofman, D., Hoes, A. W., & Grobbee, D. E. (1996) · Stroke · doi:10.1161/01.str.27.9.1499 · Cited by 124
Self-citationThe International Classification of Primary Care in the European Community: FIG
Pringle, M. (1994) · BMJ · doi:10.1136/bmj.308.6921.144a · Cited by 114
Bots, M. L., Launer, L. J., Lindemans, J. W., Albert Hofman, D., & Grobbee, D. E. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00239.x · Cited by 112
Self-citationMolecular genetic aspects of hyperhomocysteinemia and its relation to folic acid.
Rozen, R. R. (1996) · PubMed · Cited by 62
Psaty, B. M., Koepsell, T. D., Manolio, T. A., Longstreth, W. T., Jr., Wagner, E. H., WAHL, P. W., & Kronmal, R. A. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90079-5 · Cited by 61
Incidence and Risk Factors of Ischaemic and Haemorrhagic Stroke in Europe
Grobbee, D. E., Koudstaal, P. J., Bots, M. L., Amaducci, L. A., Elwood, P. C., Ferro, J. M., de Concalves, A. F., Krüger, Ø., Inzitari, D., Nikitin, Y., et al. (1996) · Neuroepidemiology · doi:10.1159/000109919 · Cited by 22
Self-citation
Cited by
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Silent brain infarcts: a systematic review
Vermeer, S. E., Longstreth, W. T., & Koudstaal, P. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70170-9 · Cited by 1,221
Self-citationHomocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
Metadata
- Authors
- Bots, M. L., Launer, L. J., Lindemans, J., Hoes, A. W., Hofman, A., Witteman, J. C. M., Koudstaal, P. J., & Grobbee, D. E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1999-01-11
- Volume
- 159
- Issue
- 1
- Pages
- 38
- ISSN
- 0003-9926
- OpenAlex
- W1986418570
- Cited by
- 260
- References
- 33
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.